You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

atypical antipsychotic

Showing 26 - 50 of 1,498
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Weight Gain, Autism Spectrum Disorder, Medication Side Effect Trial in Nashville (Comparison of Risperidone and Aripiprazole)

Recruiting
  • Weight Gain
  • +2 more
  • Comparison of Risperidone and Aripiprazole
  • Nashville, Tennessee
    Division of Developmental Medicine
Mar 10, 2022

Eating Disorders Trial in New York (Olanzapine, Placebo)

Completed
Has Results
  • Eating Disorders
  • New York, New York
    Eating Disorders Clinic, New York State Psychiatric Institute
Apr 18, 2019

Schizophrenia (Recent-onset) Trial in Los Angeles (paliperidone palmitate, risperidone)

Completed
  • Schizophrenia (Recent-onset)
  • Los Angeles, California
    UCLA Semel Institute for Neuroscience and Human Behavior
Apr 7, 2022

Post Traumatic Stress Disorder Trial in San Antonio (Quetiapine Fumarate, Standard of care meducations)

Active, not recruiting
  • Post Traumatic Stress Disorder
  • Quetiapine Fumarate
  • Standard of care meducations
  • San Antonio, Texas
    UT Health San Antonio
Apr 29, 2022

Tardive Dyskinesia, Intellectual Disability, Developmental Disabilities Trial in Cleveland (Valbenazine Oral Capsule)

Not yet recruiting
  • Tardive Dyskinesia
  • +2 more
  • Valbenazine Oral Capsule
  • Cleveland, Ohio
    University Hospitals of Cleveland
Oct 30, 2023

Schizophrenia, Antipsychotics, Long-Acting Injection Trial in Korea, Republic of (Abilify maintena)

Completed
  • Schizophrenia
  • +4 more
  • Abilify maintena
  • Chungju, Chungcheongbuk-do, Korea, Republic of
  • +26 more
Dec 16, 2021

Schizophrenia, Metabolic Syndrome, Berberine Trial in Tianjin (Berberine, Metformin)

Recruiting
  • Schizophrenia
  • +3 more
  • Tianjin, Tianjin, China
    Tianjin Anding Hospital
Feb 14, 2022

ADHD Trial in Toronto (Cariprazine)

Recruiting
  • Attention Deficit Hyperactivity Disorder
  • Toronto, Ontario, Canada
    START Clinic for Mood and Anxiety Disorders
Dec 13, 2021

Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders, Metabolic Syndrome x Trial in Tuen Mun (Berberine,

Completed
  • Schizophrenia
  • +2 more
  • Tuen Mun, Hong Kong
    Castle Peak Hospital - The Department of General Adult Psychiatr
Jan 18, 2021

Bipolar Disorder, Alcoholism, Alcohol Abuse Trial in Dallas (Aripiprazole, Placebo)

Recruiting
  • Bipolar Disorder
  • +2 more
  • Dallas, Texas
    UT Southwestern
Jan 31, 2022

Schizophrenia, Metabolic Syndrome X, Insulin Resistance Trial in San Diego (Switch, Control)

Completed
Has Results
  • Schizophrenia
  • +2 more
  • San Diego, California
    VA San Diego Healthcare System
Oct 5, 2020

Bipolar Disorder Trial in Canada (Cannabidiol, Placebo)

Not yet recruiting
  • Bipolar Disorder
  • Calgary, Alberta, Canada
  • +7 more
May 18, 2023

Schizophrenia Negative Type Trial in Tianjin (tDCS active stimulation combined with rTMS sham stimulation, rTMS active

Enrolling by invitation
  • Schizophrenia Negative Type
  • tDCS active stimulation combined with rTMS sham stimulation
  • +3 more
  • Tianjin, Tianjin, China
    Jie Li
Jan 14, 2023

Bipolar Depression, Suicidal Ideation and Behavior Trial in United States (NRX-101, Lurasidone HCl)

Recruiting
  • Bipolar Depression
  • Suicidal Ideation and Behavior
  • Miami Lakes, Florida
  • +9 more
Aug 8, 2022

Trichotillomania (Hair-Pulling Disorder), Dermatillomania Trial in Chicago (Placebo, Aripiprazole)

Not yet recruiting
  • Trichotillomania (Hair-Pulling Disorder)
  • Dermatillomania
  • Chicago, Illinois
    University of Chicago
Oct 28, 2022

Schizophrenia Trial in Dublin (LORETA, Treatment as usual)

Terminated
  • Schizophrenia
  • LORETA
  • Treatment as usual
  • Dublin, Ireland
    Tallaght University Hospital / St. James' Hospital
Mar 25, 2022

Side Effects of Antipsychotic Medications

Completed
  • Insulin Resistance
  • +4 more
    • Palo Alto, California
      VA Palo Alto Health Care System
    Mar 17, 2021

    Depressive Disorder, Major Trial (Cariprazine, Treatment as usual)

    Not yet recruiting
    • Depressive Disorder, Major
    • (no location specified)
    Jul 5, 2023

    Childhood Obesity Trial (Treatment, Control)

    Enrolling by invitation
    • Childhood Obesity
    • Treatment
    • Control
    • (no location specified)
    Nov 22, 2021

    Chemo-induced Nausea and Vomiting Trial in Chapel Hill (Olanzapine 5 MG, Placebo)

    Completed
    • Chemotherapy-induced Nausea and Vomiting
    • Olanzapine 5 MG
    • Placebo
    • Chapel Hill, North Carolina
      UNC Hospital
    Nov 28, 2022

    Borderline Personality Disorder Trial (Caplyta, Placebo)

    Not yet recruiting
    • Borderline Personality Disorder
    • (no location specified)
    May 16, 2022

    Tau Networks in Psychotic Alzheimer's Disease

    Recruiting
    • Alzheimer Disease
    • +2 more
    • [18F]-PI2620 PET scan
    • Manhasset, New York
      The Feinstein Institutes for Medical Research
    Apr 26, 2023

    MDD Trial in Paris (Telemedicine session)

    Not yet recruiting
    • Major Depressive Disorder
    • Telemedicine session
    • Paris, France
      Hôpital Pitié Salpêtrière
    Oct 6, 2023

    Schizophrenia, Schizoaffective Disorder, Bipolar Disorder Trial in Tacoma (olanzapine and melatonin)

    Active, not recruiting
    • Schizophrenia
    • +4 more
    • olanzapine and melatonin
    • Tacoma, Washington
      VA Puget Sound Health Care System
    Oct 6, 2022

    Schizophrenia, Glucose Intolerance Trial in Pittsburgh (Bromocriptine)

    Not yet recruiting
    • Schizophrenia
    • Glucose Intolerance
    • Pittsburgh, Pennsylvania
      VA Pittsburgh Healthcare System
    Oct 11, 2022